Potentiation of epidermal growth factor-induced DNA synthesis in rat hepatocytes by phenobarbitone: Possible involvement of oxidative stress and kinase activation

Carcinogenesis

Volumn 21, Issue 11, 2000, Pages 2041-2047

  Hodges, N J ^a   Orton, T C ^b   Strain, A J ^c   Chipman, J K ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b ASTRAZENECA   (United Kingdom)

^c QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CARCINOGEN; DIMETHYLUREA; DNA; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GLUTATHIONE; LIPID PEROXIDASE; MITOGEN ACTIVATED PROTEIN KINASE; PHENOBARBITAL; PROTEIN KINASE C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CYCLE S PHASE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVATION; ENZYME ACTIVITY; GENOTOXICITY; IN VIVO STUDY; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CULTURE; MALE; MITOGENESIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; WESTERN BLOTTING;

EID: 0033737211     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/21.11.2041     Document Type: Article

References (58)

1. Liver tumour promoter phenobarbital: A biphasic modulator of hepatocyte proliferation
2. Phenobarbital-induced hepatocellular proliferation: Anti-bromodeoxyuridine and anti-proliferating cell nuclear antigen immunocytochemistry
3. Modulation of insulin-like growth factor, mannose-6-phosphate receptors and transforming growth factor β1 during liver regeneration
4. Comparative enhancing effects of phenobarbital, amobarbital, diphenylhydantoin and dichlorodiphenyl-trichloroethane on 2-acetylaminofluorene induced hepatic tumourigenesis in rat
5. Expression of growth factors and growth factor receptors in the liver of C57 BL/10J mice following administration of phenobarbitone
6. Phenobarbital reduces EGF receptors and the ability of physiological concentrations of calcium to suppress hepatocyte proliferation
7. Modulation of epidermal growth factor receptors in rat hepatocytes by two liver tumour promoting regimes, a choline deficient diet and a phenobarbital diet
8. Phenobarbital decreases hepatocyte EGF receptor expression independant of protein kinase C
9. Reversible and phorbol ester specific defect of protein kinase C translocation in hepatocytes isolated from phenobarbital-treated rats
10. Transforming growth factor beta inhibits DNA synthesis in hepatocytes isolated from normal and regenerating rat liver
11. Regulation of mannose 6-phosphate/insulin like growth factor 2 receptors and TGFβ during liver tumour promotion with phenobarbital
12. TGFβ receptors type I, type II and type III in phenobarbital promoted rat liver tumours
13. Phenobarbital selectively promotes initiated cells with reduced TGFβ receptor levels
14. Negative selection in hepatic tumour promotion in relation to cancer risk assessment
15. Phenobarbital and some other liver tumour promoters stimulate DNA synthesis in cultured rat hepatocytes
16. Effects of tumour promoting agents 12-O-tetradecanoylphorbol-13-acetate and phenobarbital on DNA synthesis of rat hepatocytes in primary culture
17. Liver tumour promotion: Effect of phenobarbital on EGF and protein kinase C signal transduction and TGFβ1 expression
18. Phenobarbital enhances the formation of reactive oxygen in neoplastic rat liver nodules
19. Localization of oxidative damage by a glutathione-γ-glutamyl transpeptidase system in preneoplastic lesions in sections of livers from carcinogen-treated rats
20. Anti-oxididant prevention of tumour promoter induced inhibition of mouse hepatocyte intercellular communication
21. Inhibition of intercellular communication in rat hepatocytes by phenobarbital, 1,1,1-trichloro-2,2-bis[p-chlorophenyl]ethane (DDT) and γ-hexachlorocyclohexane (Lindane)-modification by antioxidants and inhibitors of cyclooxygenase
22. Phenobarbital induction of AP-1 binding activity mediates activation of glutathione S-transferase and quinone reductase gene expression
23. Modulation of phenobarbitone induced loss of gap junctional intercellular communication in hepatocyte couplets
24. The effect of non-genotoxic carcinogens, phenobarbital and clofibrate, on the relationship between reactive oxygen species, antioxidant enzyme expression and apoptosis
25. Effect of phenobarbital treatment on characteristics determining susceptibility to oxidants of homogenates, mitochondria and microsomes from rat liver
26. Reduced nicotinamide adenine dinucleotide phosphate (NADPH) dependent formation and breakdown of hydrogen peroxide during mixed function oxidation reactions in liver microsomes
27. Increase in liver microsomal glutathione-S-transferase activity by phenobarbital treatment of rats-possible involvement of oxidative activation via cytochrome P450
28. Prooxidant states and tumour promotion
29. Oxidative DNA damage caused by persistent peroxisome proliferation: Its role in hepatocarcinogenesis
30. Tobacco smoke tumour promoters, catechol and hydroquinone, induce oxidative regulation of protein kinase C and influence invasion and metastasis of lung carcinoma cells
31. Evidence that in situ generated reactive oxygen species act as a potent stage 1 tumour promoter in mouse skin
32. Tumor progression and oxidant antioxidant status
33. Antioxidants inhibit the enhancement of malignant cell transformation induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin
34. Activation of protein kinase C by redox cycling quinones
35. Translocation and enhancement of phosphotransfersase activity of protein kinase C following exposure in mouse epidermal cells to oxidants
36. 4-induced oxidative stress
37. Sublethal levels of oxidant stress stimulate multiple serine/threonine kinases and suppress protein phosphatases in jurkat T cells
38. Free radical induced changes in cell signal transduction
39. Preparation of isolated rat liver cells
40. A fluorometric method for determination of oxidised and reduced glutathione in tissues
41. Hormone and tumour promoter-induced activation or membranous association of protein kinase C in intact cells
42. EGF receptors of hepatocytes from rats treated with phenobarbitone are sensitised to down-regulation by phenobarbital in culture
43. Testing for induction of DNA synthesis in human hepatocyte primary culture by rat liver tumour promoters
44. Terminal differentiation of human promyelocytic leukemia cells induced by dimethylsulfoxide and other polar compounds
45. Tropomysin synthesis accompanies formation of actin filaments in embryonal carcinoma cells induced to differentiate by hexamethyl-bis-acetamide
46. Effects of oxygen radical scavengers on connexin 32 and 26 expression in primary cultures of adult rat hepatocytes
47. Phenobarbital-responsive nuclear translocation of the receptor CAR in induction of the CYP 2B1 gene
48. NF-kappa B is involved in induction of the rat hepatic alpha 1-acid glycoprotein gene by phenobarbital
49. Multiple autophosphorylation sites of the epidermal growth factor receptor are essential for receptor kinase activity and internalisation
50. Mitogen activated protein kinase activation in hepatocyte growth factor-stimulated rat hepatocytes: Involvement of protein tyrosine kinase and protein kinase C
51. Increasing complexity of RAS signaling
52. Signaling by dual specific kinases
53. Identification of high affinity phorbol ester receptor in cytosol of EL4 thymoma cells: Requirement for calcium, magnesium and phospholipids
54. Role of diacylglycerol (DAG) in hormonal induction of S phase in hepatocytes: The DAG-dependent protein kinase C pathway is not activated by epidermal growth factor (EGF), but is involved in mediating the responsiveness to EGF by vasopressin, angiotensin II and norepinephrine
55. Inhibition of gap junctional intercellular communication by barbiturates in long term primary cultured rat hepatocytes is correlated with liver tumour promoting activity
56. Connections with connexins: The molecular basis of direct intercellular signaling
57. Generation of reactive oxygen species in a human keratinocyte cell line: Role of calcium
58. Redox regulation of signal transduction in mammalian cells